Dihydroartemisinin as a Putative STAT3 Inhibitor, Suppresses the Growth of Head and Neck Squamous Cell Carcinoma by Targeting Jak2/STAT3 Signaling
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dihydroartemisinin as a Putative STAT3 Inhibitor, Suppresses the Growth of Head and Neck Squamous Cell Carcinoma by Targeting Jak2/STAT3 Signaling
Authors
Keywords
Cancer treatment, Apoptosis, Cell cycle and cell division, STAT signaling, Head and neck squamous cell carcinoma, Mouse models, Cell cycle inhibitors, Signal inhibition
Journal
PLoS One
Volume 11, Issue 1, Pages e0147157
Publisher
Public Library of Science (PLoS)
Online
2016-01-20
DOI
10.1371/journal.pone.0147157
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignancies
- (2015) A. L. Wong et al. ANNALS OF ONCOLOGY
- Pentoxifylline inhibits melanoma tumor growth and angiogenesis by targeting STAT3 signaling pathway
- (2013) Mohammad Zahid Kamran et al. BIOMEDICINE & PHARMACOTHERAPY
- Stability and antiviral activity against human cytomegalovirus of artemisinin derivatives
- (2013) A. Flobinus et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- LBH589 Inhibits proliferation and metastasis of hepatocellular carcinoma via inhibition of gankyrin/stat3/akt pathway
- (2013) Xuan Song et al. Molecular Cancer
- Design, Synthesis and Evaluation of the Antibacterial Enhancement Activities of Amino Dihydroartemisinin Derivatives
- (2013) Chong Wu et al. MOLECULES
- STAT3 suppresses transcription of proapoptotic genes in cancer cells with the involvement of its N-terminal domain
- (2013) Olga A. Timofeeva et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dihydroartemisinin exhibits antitumor activity toward hepatocellular carcinoma in vitro and in vivo
- (2012) Chris Zhiyi Zhang et al. BIOCHEMICAL PHARMACOLOGY
- Diindolylmethane suppresses ovarian cancer growth and potentiates the effect of cisplatin in tumor mouse model by targeting signal transducer and activator of transcription 3 (STAT3)
- (2012) Prabodh K Kandala et al. BMC Medicine
- Hypoxia-induced decreases in SOCS3 increase STAT3 activation and upregulate VEGF gene expression
- (2012) Kiyotaka Yokogami et al. Brain Tumor Pathology
- Targeting Stat3 Abrogates EGFR Inhibitor Resistance in Cancer
- (2012) M. Sen et al. CLINICAL CANCER RESEARCH
- Novel synthetic derivatives of the natural product berbamine inhibit Jak2/Stat3 signaling and induce apoptosis of human melanoma cells
- (2012) Sangkil Nam et al. Molecular Oncology
- Targeting STAT3 inhibits growth and enhances radiosensitivity in head and neck squamous cell carcinoma
- (2012) Makoto Adachi et al. ORAL ONCOLOGY
- Small-molecule STAT3 Signaling Pathway Modulators from Polygonum cuspidatum
- (2012) Jiawei Liu et al. PLANTA MEDICA
- Interruption of the MEK/ERK signaling cascade promotes dihydroartemisinin-induced apoptosis in vitro and in vivo
- (2011) Ning Gao et al. APOPTOSIS
- Anti-inflammatory and immunomodulatory mechanisms of artemisinin on contact hypersensitivity
- (2011) Tan Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Indirubin inhibits tumor growth by antitumor angiogenesis via blocking VEGFR2-mediated JAK/STAT3 signaling in endothelial cell
- (2011) Xiaoli Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- Small molecules, LLL12 and FLLL32, inhibit STAT3 and exhibit potent growth suppressive activity in osteosarcoma cells and tumor growth in mice
- (2011) Grace-Ifeyinwa Onimoe et al. INVESTIGATIONAL NEW DRUGS
- Dihydroartemisinin accelerates c-MYC oncoprotein degradation and induces apoptosis in c-MYC-overexpressing tumor cells
- (2010) Jin-Jian Lu et al. BIOCHEMICAL PHARMACOLOGY
- Head and neck cancer
- (2010) David M. Cognetti et al. CANCER
- The anti-cancer activity of dihydroartemisinin is associated with induction of iron-dependent endoplasmic reticulum stress in colorectal carcinoma HCT116 cells
- (2010) Jin-Jian Lu et al. INVESTIGATIONAL NEW DRUGS
- Dihydroartemisinin Induces Apoptosis by a Bak-Dependent Intrinsic Pathway
- (2010) R. Handrick et al. MOLECULAR CANCER THERAPEUTICS
- The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors
- (2009) Michael Hedvat et al. CANCER CELL
- Bortezomib up-regulates activated signal transducer and activator of transcription-3 and synergizes with inhibitors of signal transducer and activator of transcription-3 to promote head and neck squamous cell carcinoma cell death
- (2009) C. Li et al. MOLECULAR CANCER THERAPEUTICS
- Combined Targeting of Epidermal Growth Factor Receptor, Signal Transducer and Activator of Transcription-3, and Bcl-XL Enhances Antitumor Effects in Squamous Cell Carcinoma of the Head and Neck
- (2008) A. L. Boehm et al. MOLECULAR PHARMACOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started